.jpeg)
2026-10-28 06:45:09
Ganaxolone treats seizures associated with CDD in patients aged 2 and older by enhancing GABA-A receptor inhibition. It reduces seizure frequency but does not correct the underlying CDKL5 gene defect.
2026-10-28 06:09:14
Daraxonrasib is a structurally complex oral small-molecule pan-RAS(ON) inhibitor that uses cyclophilin A to form a tri-complex, blocking active RAS downstream signaling in RAS-driven tumors.
2026-10-28 06:04:10
A drop in growth velocity on vosoritide does not automatically mean resistance. Evaluate serial height data, weight-based dosing, injection adherence, and epiphyseal status before changing therapy.
2026-10-27 02:37:41
Ramosetron orally disintegrating tablets are for adult diarrhea-predominant IBS. They modulate 5-HT3 receptors, with separate male/female dosing and a 3-month treatment review.
2026-10-27 02:14:42
Breast cancer patients on tamoxifen often report feeling older due to hot flashes, sleep issues, and skin changes. This guide explains the side effects and coping tips.
2026-10-27 02:10:41
Acoramidis is an oral TTR stabilizer for adults with wild-type or hereditary transthyretin amyloidosis cardiomyopathy, aimed at lowering cardiovascular death and hospitalization risk rather than removing deposited amyloid.
2026-10-26 03:05:56
Vosoritide powder needs 2–8°C refrigeration and protection from light, never freezing. Unreconstituted product may sit at room temperature for up to 90 days but cannot go back to the fridge. After reconstitution, use within 3 hours.
2026-10-26 03:01:21
In October 2026, FDA granted traditional approval to pembrolizumab and Keytruda Qlex for unresectable or metastatic TMB-H solid tumors with TMB≥13 mut/Mb. KEYNOTE-158 showed ORR 36%; immune-mediated adverse reactions require vigilance.
2026-10-26 02:57:48
Capmatinib is a selective MET inhibitor for adults with MET exon 14 skipping metastatic NSCLC. Standard dose 400mg twice daily; watch ILD, hepatotoxicity, peripheral edema, photosensitivity.
2026-10-23 06:13:37
Vosoritide common reactions are injection-site redness/itching/pain, vomiting, and transient low blood pressure. Eat and hydrate before dosing to reduce dizziness; seek care for severe signs, do not self-adjust.
2026-10-23 06:00:55
Ribociclib is a CDK4/6 inhibitor for HR-positive, HER2-negative breast cancer. Adjuvant use lowers recurrence risk; advanced use controls progression with endocrine therapy. It does not guarantee no metastasis and is not self-managed.
2026-10-23 05:44:41
Pretomanid is a nitroimidazole prodrug activated by mycobacterial Ddn/F420; it inhibits mycolic acid aerobically and poisons respiration anaerobically. Used only with bedaquiline + linezolid for selected adult resistant pulmonary TB.
